Biocept Inc. Launches First Liquid Biopsy Test For Colorectal Cancer

Biocept, Inc. (BIOC) today announced the launch of a new liquid biopsy diagnostic test for colorectal cancer.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.